Riber S.A. of Bezons, France – which manufactures molecular beam epitaxy (MBE) systems as well as evaporation sources and effusion cells – has reported revenue of €11.6m for first-half 2020, down 17% on first-half 2019’s €13.9m. Business shows a good level of resilience despite an environment disrupted by the COVID-19 pandemic and the lockdown measures, which have delayed certain deliveries, says the firm...